Mast Therapeutics

110 articles about Mast Therapeutics

• Mast Therapeutics Closes $8 Million Public Offering

  2/17/2016

• Mast Therapeutics Announces Proposed Public Offering Of Common Stock And Warrants

  2/10/2016

• Mast Therapeutics Announces Pricing Of Underwritten Public Offering

  2/10/2016

• Mast Therapeutics To Present At 2016 BIO CEO & Investor Conference On February 8th

  2/2/2016

• Mast Therapeutics' AIR001 Selected By The Heart Failure Clinical Research Network For Evaluation In A 100-Patient Multicenter Phase 2 Study

  2/1/2016

• Mast Therapeutics Announces Positive Top-Line Results From Phase 2a Study Of AIR001 In Patients With Heart Failure With Preserved Ejection Fraction (HFpEF) Conducted At Mayo Clinic

  2/1/2016

• Mast Therapeutics Provides Business Update

  1/7/2016

• Mast Therapeutics To Present At The Piper Jaffray 27th Annual Healthcare Conference

  11/24/2015

• Mast Therapeutics Release: Vepoloxamer Data Selected For Presentation At 57th Annual American Society of Hematology Meeting

  11/16/2015

• Mast Therapeutics Reports Third Quarter 2015 Financial Results

  11/12/2015

• Mast Therapeutics Release: Vepoloxamer Nonclinical Study Results In Advanced Heart Failure To Be Presented At 2015 American Heart Association Scientific Sessions

  11/9/2015

• Mast Therapeutics Announces Appointment Of Peter Greenleaf To Board of Directors

  11/9/2015

• Mast Therapeutics Announces Appointment Of Matthew Pauls To Board Of Directors

  11/2/2015

• Mast Therapeutics To Host Third Quarter 2015 Financial Results And Corporate Update Conference Call

  10/29/2015

• Mast Therapeutics Initiates Phase 2 Study Of Vepoloxamer For The Treatment Of Chronic Heart Failure

  10/26/2015

• BASF To Develop A High Purity Poloxamer For Mast Therapeutics

  10/13/2015

• Mast Therapeutics Announces Amendment To Loan And Security Agreement With Hercules Technology Growth Capital

  9/30/2015

• Mast Therapeutics Announces Presentation Of Results Of Nonclinical Study Of Vepoloxamer In Chronic Heart Failure At The HFSA's Annual Scientific Meeting

  9/28/2015

• Mast Therapeutics To Host Analyst & Investor Day On October 7, 2015

  9/24/2015

• Mast Therapeutics To Host Second Quarter 2015 Financial Results And Corporate Update Conference Call

  8/6/2015